Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M37,374Revenue (TTM) $M4,732Net Margin (%)16.5Altman Z-Score11.9
Enterprise Value $M36,348EPS (TTM) $6.8Operating Margin %25.7Piotroski F-Score6
P/E(ttm)52.5Beneish M-Score-2.8Pre-tax Margin (%)25.7Higher ROA y-yN
Price/Book8.310-y EBITDA Growth Rate %--Quick Ratio3.3Cash flow > EarningsY
Price/Sales8.75-y EBITDA Growth Rate %--Current Ratio3.6Lower Leverage y-yY
Price/Free Cash Flow49.2y-y EBITDA Growth Rate %0.9ROA % (ttm)13.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)20.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M105ROIC % (ttm)24.6Gross Margin Increase y-yY

Gurus Latest Trades with REGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
REGNKen Fisher 2016-12-31 Add$336.01 - $444.52
($380.27)
$ 356.92-6%Add 15.32%715
REGNJoel Greenblatt 2016-09-30 Reduce-0.02%$358.5 - $441.37
($401.14)
$ 356.92-11%Reduce -17.93%24,745
REGNGeorge Soros 2016-09-30 Buy 0.02%$358.5 - $441.37
($401.14)
$ 356.92-11%New holding1,381
REGNMario Gabelli 2016-09-30 Reduce$358.5 - $441.37
($401.14)
$ 356.92-11%Reduce -60.20%529
REGNKen Fisher 2016-09-30 Add$358.5 - $441.37
($401.14)
$ 356.92-11%Add 1.14%620
REGNRon Baron 2016-09-30 Reduce$358.5 - $441.37
($401.14)
$ 356.92-11%Reduce -1.26%4,924
REGNJoel Greenblatt 2016-06-30 Add0.12%$331.05 - $427.2
($384.74)
$ 356.92-7%Add 1094.10%30,151
REGNVanguard Health Care Fund 2016-06-30 Add0.08%$331.05 - $427.2
($384.74)
$ 356.92-7%Add 3.46%3,279,190
REGNMario Gabelli 2016-06-30 Reduce$331.05 - $427.2
($384.74)
$ 356.92-7%Reduce -1.04%1,329
REGNRon Baron 2016-06-30 Reduce$331.05 - $427.2
($384.74)
$ 356.92-7%Reduce -0.48%4,987
REGNVanguard Health Care Fund 2016-03-31 Add0.71%$359.68 - $542.87
($414.39)
$ 356.92-14%Add 38.98%3,169,490
REGNRon Baron 2016-03-31 Reduce-0.01%$359.68 - $542.87
($414.39)
$ 356.92-14%Reduce -32.86%5,011
REGNJoel Greenblatt 2016-03-31 Reduce-0.01%$359.68 - $542.87
($414.39)
$ 356.92-14%Reduce -39.26%2,525
REGNMario Gabelli 2016-03-31 Reduce$359.68 - $542.87
($414.39)
$ 356.92-14%Reduce -2.54%1,343
REGNKen Fisher 2016-03-31 Reduce$359.68 - $542.87
($414.39)
$ 356.92-14%Reduce -0.33%613
REGNVanguard Health Care Fund 2015-12-31 Reduce-0.17%$459.82 - $587.09
($543.11)
$ 356.92-34%Reduce -6.84%2,280,494
REGNJoel Greenblatt 2015-12-31 Buy 0.02%$459.82 - $587.09
($543.11)
$ 356.92-34%New holding4,157
REGNKen Fisher 2015-12-31 Add$459.82 - $587.09
($542.9)
$ 356.92-34%Add 22.02%615
REGNMario Gabelli 2015-12-31 Reduce$459.82 - $587.09
($543.11)
$ 356.92-34%Reduce -35.76%1,378
REGNVanguard Health Care Fund 2015-09-30 Reduce-0.32%$451.82 - $592.4
($537.03)
$ 356.92-34%Reduce -11.45%2,447,894
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

REGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


REGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2017-01-11Buy87,298$369.71-3.46view
BAKER CHARLES ADirector 2016-12-12Sell3,000$392.02-8.95view
RYAN ARTHUR FDirector 2016-11-15Sell2,000$429.34-16.87view
GOLDSTEIN JOSEPH LDirector 2016-11-14Sell2,125$450-20.68view
GOLDSTEIN JOSEPH LDirector 2016-07-29Sell2,125$425-16.02view
Sanofi10% Owner 2016-06-14Buy64,731$363.86-1.91view
RYAN ARTHUR FDirector 2016-05-24Sell1,000$396.64-10.01view
Van Plew Daniel PEVP & General Mgr Industrial O 2016-05-18Sell4,413$385.77-7.48view
GOLDSTEIN JOSEPH LDirector 2016-04-06Sell2,000$425-16.02view
GOLDSTEIN JOSEPH LDirector 2016-03-21Sell2,000$375-4.82view

Quarterly/Annual Reports about REGN:

News about REGN:

Articles On GuruFocus.com
A Green Light on Bayer Jan 19 2017 
Largest Insider Trades of the Week Jan 16 2017 
Take a Look at Sanofi Oct 05 2016 
3 of Frank Sands' Top 5 Transactions in 2nd Quarter Were Reductions Aug 14 2016 
Edward Owens Top 2nd Quarter Investments Aug 03 2016 
Frank Sands Sells Visa, Baidu, Alibaba May 24 2016 
Baron Funds Comments on Regeneron Pharmaceuticals May 23 2016 
Market-Beating Vanguard Health Care Fund Adds Shares to 5 Positions May 03 2016 
Vanguard Boosts Stake in Incyte in 1st Quarter May 02 2016 
Amgen: Should I Just Sit and Wait? Mar 18 2016 

More From Other Websites
Failed Mergers Cast Shadow on Sanofi's Future Jan 23 2017
Regeneron Pharmaceuticals Could Be Ready to Rebound Jan 20 2017
These Insiders Are Still Finding Some Good Value in the Stock Market Jan 19 2017
Regeneron, Sanofi Claim Amgen's LDL-Buster Patent Too Broad Jan 17 2017
Key FDA Events to Watch Out for in Q1 Jan 17 2017
Odds Are Against Regeneron, Sanofi In Amgen Patent Battle: Leerink Jan 13 2017
Regeneron, Sanofi's Drug Manufacturing Plant Cleared Jan 12 2017
Merrill Lynch Has 4 Red-Hot Stocks to Buy With Up to 75% Upside Potential Jan 12 2017
Trump's Comments Are Big Pharma's Nightmare Jan 11 2017
Trump's Comments Are Big Pharma's Nightmare Jan 11 2017
Todd Hagopian's Top Biotech Takeover Targets For 2017 Jan 10 2017
Regeneron CEO: The industry doesn't put patients first Jan 10 2017
The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regeneron... Jan 10 2017
Amgen Inks Multiple Deals, Offers Update on Repatha Lawsuit Jan 10 2017
Regeneron CEO says Amgen not putting patients first in patent dispute Jan 09 2017
Regeneron CEO says Amgen not putting patients first in patent dispute Jan 09 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)